CA
CHI Advisors’s Kezar Life Sciences KZR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-689,451
| Closed | -$2.16M | – | 26 |
|
|
2023
Q1 | $2.16M | Sell |
689,451
-1,200,000
| -64% | -$3.76M | 0.57% | 18 |
|
|
2022
Q4 | $13.3M | Buy |
1,889,451
+126,658
| +7% | +$892K | 3.54% | 8 |
|
|
2022
Q3 | $15.2M | Sell |
1,762,793
-78,000
| -4% | -$672K | 4.08% | 6 |
|
|
2022
Q2 | $15.2M | Buy |
1,840,793
+1,526,181
| +485% | +$12.6M | 5.81% | 6 |
|
|
2022
Q1 | $5.23M | Buy |
314,612
+42,362
| +16% | +$704K | 2.22% | 10 |
|
|
2021
Q4 | $4.55M | Buy |
272,250
+197,250
| +263% | +$3.3M | 1.51% | 14 |
|
|
2021
Q3 | $648K | Sell |
75,000
-71,680
| -49% | -$619K | 0.19% | 18 |
|
|
2021
Q2 | $796K | Sell |
146,680
-27,489
| -16% | -$149K | 0.19% | 18 |
|
|
2021
Q1 | $1.04M | Buy |
174,169
+39,169
| +29% | +$233K | 0.21% | 16 |
|
|
2020
Q4 | $705K | Sell |
135,000
-111,643
| -45% | -$583K | 0.2% | 16 |
|
|
2020
Q3 | $1.19M | Sell |
246,643
-94,330
| -28% | -$457K | 0.42% | 13 |
|
|
2020
Q2 | $1.77M | Sell |
340,973
-117,914
| -26% | -$611K | 0.69% | 9 |
|
|
2020
Q1 | $2M | Buy |
458,887
+304,632
| +197% | +$1.33M | 4.72% | 6 |
|
|
2019
Q4 | $619K | Buy |
154,255
+6,163
| +4% | +$24.7K | 0.47% | 12 |
|
|
2019
Q3 | $486K | Buy |
+148,092
| New | +$486K | 0.47% | 13 |
|